FOTIVDA vs KEYTRUDA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. FOTIVDA and KEYTRUDA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	FOTIVDA	KEYTRUDA
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TIVOZANIB HYDROCHLORIDE	PEMBROLIZUMAB
Manufacturer	Aveo Pharms	Merck Sharp Dohme
Dosage forms	Capsule	Injectable
Drug class	—	Programmed Death Receptor-1 Blocking Antibody
Boxed warning	None	None
Treats	Renal Cell Carcinoma	Malignant Mesothelioma, Biliary Tract Neoplasms, Urinary Bladder Neoplasms

fotivda keytruda

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

TIVOZANIB HYDROCHLORIDE

PEMBROLIZUMAB

Manufacturer

Aveo Pharms

Merck Sharp Dohme

Dosage forms

Capsule

Injectable

Drug class

—

Programmed Death Receptor-1 Blocking Antibody

Boxed warning

None

Treats

Renal Cell Carcinoma

Malignant Mesothelioma, Biliary Tract Neoplasms, Urinary Bladder Neoplasms

Frequently asked questions

What is the difference between Fotivda and Keytruda?

Fotivda contains Tivozanib Hydrochloride, while Keytruda contains Pembrolizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.